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Free radicalsProliferation of vascular smooth muscle cells is a characteristic of pathological vascular remodeling and rep-
resents a signiﬁcant therapeutic challenge in several cardiovascular diseases. Docosahexaenoic acid (DHA), a
member of the n-3 polyunsaturated fatty acids, was shown to inhibit proliferation of numerous cell types, im-
plicating several different mechanisms. In this study we examined the molecular events underlying the in-
hibitory effects of DHA on proliferation of primary human smooth muscle cells isolated from small
pulmonary artery (hPASMCs). DHA concentration-dependently inhibited hPASMC proliferation, induced G1
cell cycle arrest, and decreased cyclin D1 protein expression. DHA activated the unfolded protein response
(UPR), evidenced by increased mRNA expression of HSPA5, increased phosphorylation of eukaryotic initia-
tion factor 2α, and splicing of X-box binding protein 1. DHA altered cellular lipid composition and led to in-
creased reactive oxygen species (ROS) production. DHA-induced ROS were dependent on both intracellular
Ca2+ release and entry of extracellular Ca2+. Overall cellular ROS and mitochondrial ROS were decreased
by RU360, a speciﬁc inhibitor of mitochondrial Ca2+ uptake. DHA-induced mitochondrial dysfunction was
evidenced by decreased mitochondrial membrane potential and decreased cellular ATP content. DHA triggered
apoptosis as found by increased numbers of cleaved caspase-3- and TUNEL-positive cells. The free radical
scavenger Tempol counteracted DHA-induced ROS, cell cycle arrest, induction of UPR, and apoptosis. We
conclude that Ca2+-dependent oxidative stress is the central and initial event responsible for induction of
UPR, cell cycle arrest, and apoptosis in DHA-treated hPASMCs.
© 2012 Elsevier Inc.Open access under CC BY-NC-ND license.Vascular remodeling is a pathological process characterizedmainly
by increased proliferation or decreased apoptosis of vascular smooth
muscle cells. It is present in several cardiovascular diseases such as
stent restenosis, atherosclerosis [1], and pulmonary hypertension [2]
and represents a signiﬁcant therapeutic challenge.6; DHA, docosahexaenoic acid;
ryotic initiation factor 2α; ER,
C, human pulmonary artery
; IRE1α, inositol-requiring en-
K, protein kinase RNA-like en-
E, phosphatidylethanolamine;
species; TG, triglyceride; UPR,
in 1.
.
-NC-ND license.Clinical studies have shown beneﬁcial cardiovascular effects of n-3
polyunsaturated fatty acid (n-3 PUFA) nutritional supplementation
[3,4]. In vitro, n-3 PUFAs have antiproliferative effects on various
cell types, including vascular smooth muscle cells. Studies showed
that the n-3 PUFAs eicosapentaenoic acid and docosahexaenoic acid
(DHA) inhibit proliferation through production of oxidized species
at a low concentration [5], block cell cycle progression by inhibiting
phosphorylation of Cdk2–cyclin E complex [6], and induce apoptosis
partially through the p38 MAP kinase pathway [7,8]. However, the
exact mechanism of action still remains unknown.
Two recent studies implicated DHA in the perturbation of calcium
homeostasis in the endoplasmic reticulum (ER), resulting in: (i) acti-
vation of the unfolded protein response (UPR) and growth arrest in
human colon cancer cells [9] as well as (ii) increased mitochondrial
ROS production and cell death of murine thymocytes [10].
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70-kDa protein 5 (HSPA5/Bip) from three sensor proteins located in
the ER membrane [11], leading to: (i) reduction of protein synthesis
due to phosphorylation of the α subunit of eIF2α [12–14], (ii) IRE1α
(inositol-requiring enzyme 1α)-mediated splicing of XBP-1 transcrip-
tion factor [15,16], and (iii) induction of activating transcription factor
6 (ATF6) [17].
In this study we performed a comprehensive analysis of molecular
events triggered by DHA in primary human pulmonary artery smooth
muscle cells (hPASMCs), known to play a major role in the pa-
thology of pulmonary hypertension. We found that Ca2+-dependent
oxidative stress is the central and initial event responsible for induc-
tion of the UPR, cell cycle arrest, and apoptosis in DHA-treated
hPASMCs.
Materials and methods
Cells
Human pulmonary artery smooth muscle cells were isolated from
pulmonary arteries obtained from patients undergoing surgery for
lung cancer without a history of pulmonary vascular disease or arte-
rial hypoxemia, as described previously [18]. Brieﬂy, the adventitia
from small arteries with diameters of less than 1 mm was carefully
removed under microscopic guidance and media pieces less than
1 mm3 were placed into a ﬂask with one drop of culture medium sup-
plemented with 20% fetal calf serum (FCS). The study protocol for tis-
sue donation was approved by the institutional review board of the
Medical University of Graz in accordance with national law and
with the guidelines on Good Clinical Practice from the International
Conference on Harmonization. Written, informed consent was
obtained from each patient. Cells were grown in medium containing
5% FCS and growth factors (Lifeline Cell Technology, Frederick, MD,
USA) and used between passages 2 and 5. Purity was checked by
characteristic appearance under phase-contrast microscopy indirect
immunoﬂuorescence staining for α smooth muscle actin, smooth
muscle myosin heavy chain, and lack of von Willebrand factor
staining.
Chemicals
Antibodies against human phospho-eIF2α, total eIF2α, cyclin D1,
p21, α-tubulin, cleaved caspase-3 Alexa 488, and anti-rabbit horse-
radish peroxidase (HRP)-conjugated secondary antibody were from
Cell Signaling (Beverly, MA, USA). Taq polymerase was from Solis Bio-
dyne (Tartu, Estonia), 10× PCR buffer and dNTP mix were from Pro-
mega (Madison, WI, USA). DHA, dimethyl sulfoxide (DMSO), ethanol,
CaCl2, KCl, MgCl2, NaCl, Hepes, EGTA, glucose, 4-hydroxy-Tempol (Tem-
pol), bovine serum albumin (BSA), Triton X-100, and propidium iodide
were from Sigma (Steinheim, Germany). Tween 20 was from Bio-Rad
(Hercules, CA, USA). BAPTA-AM (cell-permeative Ca2+ chelator) and
RU360 (mitochondrial calcium uptake inhibitor) were from Merck
Biosciences (Nottingham, UK). [methyl-3H]Thymidine was from
PerkinElmer Life Sciences (Waltham, MA, USA). DHA was reconsti-
tuted in ethanol, aliquotted into glass vials under argon, and stored
at −80 °C until use. Vehicle control contained a maximum of 0.05%
ethanol or 0.1% DMSO.
Proliferation
Cells plated in 24-well plates were grown for 3 days with DHA or
vehicle control. At the end of the experiment, the cells were harvested
by trypsinization, centrifuged, and resuspended in phosphate-
buffered saline (PBS). An aliquot of cell suspension was taken for
cell number count. The numbers of viable and total cells were deter-
mined using a Casy machine (Schärfe System, Reutlingen, Germany),a pulse area-based technology for cell counting and viability testing.
Cells were harvested by trypsinization, centrifuged, resuspended in
PBS, and measured using the Casy instrument.
Thymidine incorporation
Cells were plated in 96-well plates and incubated with com-
pounds and 2 μCi/well [methyl-3H]thymidine overnight. Cells were
harvested (PerkinElmer harvester) and transferred to glass ﬁber
plates (UniFilter-96 GF/C; PerkinElmer) and radioactivity was mea-
sured in a scintillation counter (1450 Microbeta Trilux liquid scintilla-
tion and luminescence counter; Wallac).
Apoptosis and cell cycle measurements
Cleaved caspase-3 was determined in cells that were incubated for
indicated time intervals with DHA in 24-well plates, harvested by
trypsinization, washed in PBS, ﬁxed 10 min at 37 °C in 2% formalde-
hyde, and permeabilized in ice-cold methanol for 30 min. The cells
were then washed in PBS with 0.5% FCS, incubated with cleaved
caspase-3 antibody at room temperature for 45 min, washed, resus-
pended in PBS, and measured immediately on a FACSCalibur (BD Bio-
sciences, Franklin Lakes, NJ, USA) ﬂow cytometer.
TUNEL assay for detection of apoptotic cells was performed on
cells cultured and treated in glass chamber slides. Cells were washed
with PBS, ﬁxed with 4% paraformaldehyde for 1 h at room tempera-
ture, and permeabilized on ice with 0.1% Triton X-100 in 0.1% Na-
citrate solution. Afterward, the cells were incubated with reagents
from the In Situ cell death detection kit according to the manufac-
turer's instructions (Roche, Mannheim, Germany).
Cell cycle was determined ﬂow cytometrically by staining cells
with propidium iodide (PI). Cells were harvested by trypsinization,
washed with PBS, incubated at room temperature for 20 min with
50 μg/ml PI in 0.1% Na-acetate with 0.1% Triton X-100, and measured
immediately on a FACSCalibur ﬂow cytometer. Acquired data were
analyzed with CellQuest Pro software (BD Biosciences).
ROS and mitochondrial membrane potential (MMP) measurements by
ﬂow cytometry
ROSproductionwasdetermined using2′,7′-dichlorodihydroﬂuores-
cein diacetate (H2DCFDA) dye (Biotium, Hayward, CA, USA). Cells
grown in complete mediumwith 5% FCS in 24-well plates were loaded
with 10 μMH2DCFDA for 30 min. Thereafter, the mediumwas replaced
with fresh medium containing vehicle or DHA, followed by incubation
for the indicated time periods and ﬂow cytometric measurements of
ROS. For the 24-h time point cells were incubated with vehicle or DHA
for 23.5 h followed by labeling with 10 μM H2DCFDA for 30 min before
ﬂow cytometric measurements of ROS. In some experiments, 5 μM
BAPTA-AM and 10 μM RU360 were added during both labeling with
H2DCFDA and incubation with vehicle or DHA. To address the role of
the ROS scavenger Tempol, cells were preincubated with Tempol
(150 μM) or vehicle (DMSO) for 2 h (90 min before and during the
30-min labeling with H2DCFDA). Thereafter, the cells were exposed to
DHA in the presence or absence of Tempol for 3 h. At the end of the ex-
periment, the cells were harvested by trypsinization, washed, and
resuspended in PBS, followed by ﬂow cytometry.
For ROS measurements in calcium- and calcium-free buffer cells
were ﬁrst loaded with H2DCFDA in complete medium with 5% FCS
for 30 min. Then, the cells were washed with calcium- or calcium-
free buffer and incubated with vehicle or DHA in the respective buffer
for 1 h, followed by ROS measurement. Calcium-containing buffer
contained 2 mM CaCl2, 138 mM NaCl, 1 mM MgCl2, 5 mM KCl,
10 mM Hepes, 10 mM glucose, 5% FCS, pH 7.4. Calcium-free buffer
lacked CaCl2 but contained 1 mM EGTA.
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(Invitrogen, Darmstadt, Germany), a ﬂuorogenic dye. Cells were load-
ed with 1 μM MitoSOX red for 30 min, in the absence or presence of
RU360 (10 μM), followed by incubation with vehicle or DHA in the
presence or absence of RU360 for 1 h. At the end of the experiment,
the cells were harvested by trypsinization, washed, and resuspended
in PBS followed by ﬂow cytometry.
ΔΨm was measured using the Mito ID membrane potential detec-
tion kit (Enzo Life Sciences, Lorrach, Germany). Cells were incubated
for the indicated time with DHA and then harvested by trypsinization,
washed, and incubated at room temperature for 15 min with reagent
followed by ﬂow cytometry. Loss of MMP was observed as a decrease
in orange and increase in green ﬂuorescence. Results are presented as
a change in ratio of two ﬂuorescence means that correlates to changes
in ΔΨm.Array confocal laser scanning microscopy
High-resolution imaging of cells loaded with both 1 μM MitoSOX
red and 0.5 μMMitoTracker green for 30 min, followed by incubation
with vehicle or DHA, was performed using an array confocal laser
scanning microscope (ACLSM). The ACLSM was built on an inverse,
fully automatic microscope (Axio Observer.Z1 from Zeiss, Göttingen,
Germany) that was equipped with a 100× objective (Plan-Fluor
100×/1.45 oil; Zeiss), a Nipkow-based confocal scanner unit (CSU-
X1; Yokogawa Electric Corp., Tokyo, Japan), a motorized ﬁlter wheel
(CSUX1FW; Yokogawa Electric) on the emission side, and an acousto
optic tunable ﬁlter-based laser merge module for laser lines 405, 445,
473, 488, 515, and 561 nm (Visitron Systems, Pucheim, Germany).
Emission was acquired with a charged-coupled device camera (Cool-
SNAP-HQ; Photometrics, Tucson, AZ, USA). All devices were con-
trolled by VisiView Premier acquisition software (Visitron Systems).
MitoSOX red and MitoTracker green were alternatively excited at
561 and 488 nm and ﬂuorescence emission light was collected at
630/75 and 525/40 nm, respectively. Image analysis (colocalization
analysis) was performed using MetaMorph software 7.7 (Molecular
Devices, Sunnyvale, CA, USA).Adenine nucleotide analysis
Adenine nucleotides were analyzed as reported previously [19,20]
with some modiﬁcations. Separation was performed on a Hypersil
ODS column (5 μm, 250×4 mm i.d.), using a L2200 autosampler,
two L-2130 HTA pumps, and an L2450 diode array detector (all
from VWR Hitachi). The wavelength for detection of adenine nucleo-
tides was set at 254 nm. EZchrom Elite (VWR) was used for data ac-
quisition and analysis. After trypsinization and mild centrifugation
(supernatant discarded) the cellular proteins were precipitated with
250 μl of perchloric acid (0.4 mol/L, 4 °C). After centrifugation
(12,000 g), 100 μl of the supernatant was neutralized with 10–12 μl
of potassium carbonate (2 mol/L, 4 °C). The supernatant obtained
after centrifugation was used for HPLC analysis (injection volume:
40 μl). The pellets of the acid extract were dissolved in 0.5 ml of sodium
hydroxide (0.1 mol/L) and used for protein determination (BCA assay;
Pierce).Mass spectrometric determination of phospholipid and triglyceride species
Cells grown in six-well plates were treated with DHA or vehi-
cle for 20 h followed by extraction of cellular lipids according to
Bligh and Dyer [21] followed by HPLC and MS as previously de-
scribed [22,23]. For details please see the supplementary
methods.Measurement of intracellular calcium
Intracellular calcium was measured as described previously [24].
Cells were trypsinized and loaded with 2 μM Fura-2/AM for 45 min.
After being washed, the cells were resuspended in either calcium
buffer (138 mM NaCl, 1 mM MgCl2, 5 mM KCl, 10 mM Hepes,
10 mM glucose, pH 7.4) or EGTA buffer (1 mM EGTA, 138 mM NaCl,
1 mM MgCl2, 5 mM KCl, 10 mM Hepes, 10 mM glucose, pH 7.4). The
ratio of Fura-2 ﬂuorescence intensity at the two excitation wave-
lengths (340 nm/380 nm ratio) was monitored ﬂuorometrically in a
stirring cuvette before and after the injection of vehicle or 10 μM
DHA. Values obtained with vehicle were subtracted from those
obtained with DHA.
Western blot
Cells were washed once with ice-cold PBS and lysed in M-PER
mammalian protein extraction reagent (Thermo Scientiﬁc, Rockford,
IL, USA) containing protease and phosphatase inhibitors (Roche).
Equal amounts of proteins were loaded per lane and analyzed by
SDS–PAGE (10%) and subsequent immunoblotting. Nitrocellulose
membrane (Bio-Rad) was blocked in 5% milk in Tris-buffered saline
with 0.1% Tween 20 and incubated overnight at 4 °C with the indicated
primary antibody (1:1000 in 5% BSA). Thereafter, membranes were
washed and incubated with HRP-labeled secondary antibody (1:5000
in 1% milk) and developed with SuperSignal West Pico or Super-
Signal West Femto Substrate (Thermo Scientiﬁc). Membranes were
stripped using Restore Plus Western blot stripping buffer (Thermo
Scientiﬁc).
Quantitative real-time PCR (qRT-PCR)
Isolation of RNA and qRT-PCR were performed as described [23].
mRNA levels of HSPA5 (Primer Assay QT00096404), cyclin D1
(QT00495285), and p21 (QT00062090) were normalized to human
β2-microglobulin (QT01665006) and expressed as relative ratio
(ΔΔCt). All samples were assayed in duplicate and the average value
was used for quantiﬁcation.
Detection of XBP-1 splice variant
Forward (CCTTGTAGTTGAGAACCAGG) and reverse (GGGGCTTGGTA-
TATATGTGG) primers for XBP-1 PCRwere from Invitrogen. The PCR am-
pliﬁcation program consisted of 40 cycles each containing three steps:
95, 58, and 72 °C (each 1 min). Electrophoretic separation of the result-
ing products was performed on 3% agarose gel in 0.5× TAE buffer at
30 V for 6 h. Unspliced XBP-1 product had a size of 422 bp and the
spliced variant had a size of 396 bp.
Statistics
Data are given as means ± SEM. Statistical analyses were per-
formed in GraphPad Prism 5 using the paired t test, for experiments
comparing two groups, and ANOVA Kruskal–Wallis with the Dunn
multiple comparison posttest, for experiments comparing three or
more groups. Pb0.05 was considered statistically signiﬁcant.
Results
DHA inhibits hPASMC proliferation
We tested the effects of DHA on hPASMC proliferation. After
3 days of incubation with various DHA concentrations ranging from
25 to 150 μM, in fully supplemented medium with 5% FCS, prolifera-
tion was determined by cell counting (Fig. 1A) and [3H]thymidine in-
corporation (Fig. 1B). DHA in both cases dose-dependently inhibited
Fig. 1. DHA dose-dependently inhibits hPASMC proliferation. (A) Number of viable cells was determined after 3 days of incubation with indicated concentrations of DHA and results
are expressed relative to vehicle control (n=5). (B) [3H]Thymidine incorporation was measured after overnight incubation with DHA and results are expressed relative to vehicle
control (n=5). (C) Cells were treated with 100 μMDHA for 12 h and analyzed by ﬂow cytometry for DNA content. Cell cycle distribution in G1 phase is expressed as the percentage
of total cells (n=4). (D) Cells were treated with 100 μMDHA and representative time course results of p21 and cyclin D1Western blots are shown. (E and F) Densitometry evaluation of
Western blot data. Signals were normalized to α-tubulin and expressed relative to 4-h vehicle (veh) control (n=4). Data are given as means ± SEM of at least four independent experi-
ments. *Pb0.05 vs corresponding veh control group.
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plasma DHA concentration in humans, we chose to use DHA at
100 μM in all subsequent experiments.
The observed inhibitory action of DHA on cell proliferation was ac-
companied by an increased percentage of cells in G1 phase of the cell
cycle (Fig. 1C). Protein expression level of cyclin D1, a positive regulator
of cell cycle progression, was signiﬁcantly decreased in DHA-treated
cells (Figs. 1D and E). Protein expression level of p21, a negative regula-
tor of cell cycle progression, was unaltered upon DHA treatment
(Figs. 1D and F).
DHA induces UPR in hPASMCs
Decreased cyclin D1 protein might be a consequence of DHA-
induced ER stress and concomitant activation of UPR. We tested
three markers of UPR in DHA-treated cells. The levels of HSPA5
(Bip) mRNA were signiﬁcantly increased in DHA-treated cells, com-
pared with vehicle-treated control cells (Fig. 2A). Furthermore, thephosphorylation level of eIF2α was signiﬁcantly increased in DHA-
treated cells (Figs. 2B and C). Finally, splicing of XBP-1 mRNA was in-
duced upon incubation with DHA (Fig. 2D).
DHA alters the lipid proﬁle of hPASMCs
Because alterations in cellular lipid composition might be responsi-
ble for ER stress and UPR, we performed phospholipid and triglyceride
proﬁling of DHA- and vehicle-treated cells by mass spectrometry.
Both phosphatidylcholine (PC) species 38:6, 40:6, and 40:7 (Fig. 3A)
and phosphatidylethanolamine (PE) species 40:6 and 40:7 (Fig. 3B)
were markedly enriched in DHA-treated cells compared with vehicle-
treated control cells. The observed increase in PC and PE species that
contain DHA was accompanied by a marked decrease in several phos-
pholipid species that lack DHA (Figs. 3A and B). DHAwas also efﬁciently
incorporated into triglycerides (TGs) as reﬂected by the increase in TG
species containing long-chain polyunsaturated fatty acids including
DHA (not shown).
Fig. 2. DHA induces UPR in hPASMC. (A) Quantitative RT-PCR measurement of HSPA5 gene expression (n=4). (B) Representative Western blot detection of phosphorylated eIF2α.
Total eIF2α served as loading control. (C) Densitometric evaluation of eIF2α phosphorylation (n=4). (D) Representative PCR detection of XBP-1 splice variant. Data are given as
means ± SEM. *Pb0.05 vs corresponding vehicle (veh) control group.
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and UPR
To further examine whether DHA-induced oxidative stress is im-
plicated in the promotion of ER stress, we measured intracellular
ROS production in DHA-treated cells. We observed a rapid increase
in ROS production under DHA treatment, starting as soon as afterFig. 3. DHA alters cellular phospholipid composition. hPASMCs were incubated with 100 μM
lipid species. (A) DHA-induced alterations in cellular phosphatidylcholine proﬁle. (B) DHA-10 min incubation, with a maximum after 1 and 3 h, followed by a de-
creasing trend after 5 h and similar levels in DHA- and vehicle-treated
cells after 24 h (Fig. 4A). DHA-induced ROS were signiﬁcantly de-
creased by preincubation with the free radical scavenger Tempol
(Fig. 4B). Tempol markedly recovered both DHA-mediated inhibition
of cell proliferation (Fig. 4C) and cyclin D1 protein expression (Fig. 4D)
and diminished DHA-induced phosphorylation of eIF2α (Fig. 4E).DHA for 20 h followed by lipid extraction and mass spectrometric analysis of phospho-
induced alterations in cellular phosphatidylethanolamine proﬁle.
Fig. 4. Free radical scavenger Tempol attenuates DHA-induced oxidative stress and UPR and improves cell proliferation. (A) Cells were loaded with 10 μM H2DCFDA for 30 min fol-
lowed by exposure to veh or DHA (100 μM) for indicated time periods up to 5 h, followed by ﬂow cytometry. For the 24-h time point cells were incubated with veh or DHA for
23.5 h and then loaded with H2DCFDA for 30 min in the presence of veh or DHA, followed by ﬂow cytometry. (B) Cells were preincubated with Tempol (150 μM) or veh
(DMSO) for 2 h (90 min before loading and during 30-min loading with H2DCFDA). Thereafter, the cells were exposed to DHA in the presence or absence of Tempol for 3 h, followed
by ROS measurement. (C) [3H]Thymidine incorporation in veh- or DHA-treated hPASMCs in the absence and presence of Tempol. (D) Representative Western blot of cyclin D1 pro-
tein expression in veh- or DHA-treated hPASMCs in the presence and absence of Tempol. (E) RepresentativeWestern blot of phosphorylated eIF2α in veh- or DHA-treated hPASMCs
in the presence and absence of Tempol. Total eIF2α served as loading control. Data are given as means ± SEM of at least ﬁve independent experiments. *Pb0.05.
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To identify the underlying mechanisms responsible for ROS genera-
tion upon DHA treatment, we addressed whether Ca2+ triggers ROS
generation. For this purpose cells were loaded with the intracellular
Ca2+ chelator BAPTA-AM. Cells loaded with BAPTA-AM showed de-
creased ROS production in response to DHA (Fig. 5A). To examine the
role of Ca2+ in DHA-induced ROS production in more detail, we ﬁrst
tested the capacity of DHA to modulate the cytosolic Ca2+ concentra-
tion ([Ca2+]i). DHA increased [Ca2+]i in the absence and even more in
the presence of extracellular Ca2+ (Fig. 5B). The importance of extracel-
lular Ca2+ for DHA-induced ROS was demonstrated by decreased ROS
in cells treated with DHA in the absence of extracellular Ca2+ (EGTA
buffer) compared with cells in the presence of extracellular Ca2+ (Ca2+
buffer; Fig. 5C). Overall cellular DHA-induced ROS was decreased in
the presence of RU360, a speciﬁc inhibitor of Ca2+ uptake into mito-
chondria (Fig. 5D). Also the DHA-induced increase in mitochondrial
ROS, measured in MitoSOX red-loaded cells, was markedly decreased
by RU360 (Fig. 5E). The majority of MitoSOX red accumulated in mito-
chondria as found by its colocalization with a mitochondria-speciﬁc
marker, MitoTracker green (Supplementary Fig. 1).
DHA induces ΔΨm dissipation, ATP depletion, and apoptosis in hPASMCs
Both quantiﬁcation of cleaved caspase-3-positive cells and TUNEL
assay showed signiﬁcant induction of apoptosis upon prolonged DHA
treatment (Figs. 6A and B). Importantly, Tempol markedly diminished
DHA-induced apoptosis (Fig. 6C). Furthermore, DHA caused mito-
chondrial dysfunction as reﬂected by decreased ΔΨm in DHA-
treated cells (Fig. 6D). In line with the decreased ΔΨm, the cellular
ATP content (Fig. 6E) and the ATP/ADP ratio (Fig. 6F) were decreased
in DHA-treated cells, compared with respective control cells.Discussion
The major ﬁnding of this study is that DHA-induced oxidative
stress is the initial and central event responsible for the induction of
UPR, inhibition of cell proliferation, and induction of apoptosis in
hPASMCs.
These effects of DHA were observed in fully supplemented medium
containing serum and growth factors, thus closely resembling the in
vivo conditions. Importantly, the applied concentrations of DHA, exhibit-
ing an antiproliferative effect in hPASMCs, were within physiologically/
pharmacologically reachable levels in human serum [25–29].
In accordance with the described antiproliferative effect of DHA
[30], the proliferation rate of hPASMCs was markedly decreased by
DHA. This decrease was accompanied by an increased number of
cells in the G1 phase of the cell cycle and a decreased cyclin D1 pro-
tein content. Most probably the observed decrease in cyclin D1 re-
ﬂects a general attenuation of protein synthesis due to activation of
the protein kinase RNA-like endoplasmic reticulum kinase (PERK)/
eIF2α signaling pathway connected with ER stress. Indeed, we
found increased levels of phosphorylated eIF2α and HSPA5 as well
as the appearance of a spliced variant of XBP-1, indicative of UPR ac-
tivation upon DHA treatment. DHA was found to induce ER stress and
UPR in colon cancer cells [9]. However, a recent publication showed
no evidence of ER stress or UPR in DHA-treated rat hepatocytes
[31], indicating species- and cell-type-speciﬁc cellular responses to
DHA. Alternatively, decreased cyclin D1 levels might be due to
PERK/eIF2α-mediated increase in cyclin D1 proteasomal degradation,
independent of the efﬁcacy of translation [32].
Because protein folding and posttranslational protein modiﬁcations
are highly sensitive to alterations in the ER luminal environment, we
examined the impact of DHA on cellular lipid composition, ROS produc-
tion, and intracellular Ca2+ homeostasis. In addition to a marked
Fig. 5. Ca2+ and mitochondria are involved in DHA-induced ROS production. (A) hPASMCs were loaded with H2DCFDA (10 μM) in the presence or absence of BAPTA-AM (5 μM) for
30 min. Then, the cells were further incubated with vehicle (veh) or 100 μMDHA in the presence or absence of BAPTA-AM for 1 h, followed by ROS measurement by ﬂow cytometry.
(B) Fura-2/AM-loaded hPASMCs were resuspended in either Ca2+-containing buffer ([Ca2+]) or Ca2+-free buffer containing EGTA (EGTA). The ratio of Fura-2 ﬂuorescence inten-
sity at the two excitation wavelengths (340/380 nm ratio) was monitored ﬂuorometrically in a stirring cuvette during exposure to veh or 10 μM DHA. Results are representative
single traces of three experiments performed in duplicate. Values for veh were subtracted from those obtained with DHA. (C) Cells were loaded with H2DCFDA in complete medium
with 5% FCS for 30 min. Then, the cells were washed with calcium-containing or calcium-free buffer and incubated with vehicle or DHA in the respective buffer for 1 h, followed by
ROS measurement. (D) Cells were loaded with H2DCFDA in the absence or presence of RU360 for 30 min. Thereafter, the cells were incubated with veh, RU360 (10 μM), or DHA ±
RU360 for 1 h, followed by ﬂow cytometric measurement of ROS. (E) The procedure was exactly as described for (D) except that cells were loaded with MitoSOX red (1 μM). Unless
stated otherwise, data are given as means ± SEM of six independent experiments. *Pb0.05.
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crease in PC and PE species containingmono- (18:1) and di- (18:2) un-
saturated fatty acids. This lipid proﬁle is partly similar to that reported
for HeLa cells, in which stearoyl-CoA desaturase 1 (SCD1) knockdown
decreased membrane phospholipid unsaturation, particularly 18:1
fatty acid, leading to UPR and apoptosis [33]. Although SCD1 mRNA
levels were not signiﬁcantly altered by DHA in our study (not shown),
the possibility remains that SCD1 activity is impaired by DHA, leading to
the observed lipid proﬁle. Alternatively, DHA might compete with 18:1,
18:2, and other fatty acids for lysophosphatidylcholine acyltransferase-
mediated incorporation into cellular phospholipids [34]. Disturbed con-
formation and consequently dysfunction of ER-membrane-associated
chaperones, with concomitant accumulation of unfolded proteins,
might therefore be an explanation for the observed induction of ER
stress and UPR upon perturbations in phospholipid composition.
The observed DHA-induced ROS production was very rapid in
onset, suggesting an acute cellular response to DHA as an underlying
mechanism. Indeed, DHA induced a rapid increase in cytosolic calcium
(Fig. 5B), a prerequisite for DHA-induced ROS formation (Fig. 5A). In
line with the previously described mechanism of the DHA-inducedincrease in cytosolic calcium [35], both Ca2+ released from ER and
Ca2+ entry contributed to DHA-induced increase in cytosolic Ca2+
levels (Fig. 5B),which triggered ROS generation (Figs. 5A and C). Impor-
tantly, prolonged exposure of cells to DHA (5 h) did not alter the
amount of ionomycin-releasable Ca2+ (not shown), indicating that
steady-state ER Ca2+ levels were not altered upon prolonged exposure
to DHA. Accordingly, depletion of ER Ca2+ seems not to be the trigger of
ER stress and UPR in DHA-treated cells. Rather, the DHA-induced, Ca2+-
dependent oxidative stress seems to be responsible for the initiation of
UPR and apoptosis. Indeed, Tempol, a strong antioxidant, diminished
the amounts of both phosphorylated eIF2α and cleaved caspase-3-
positive cells.
It is well established that increased mitochondrial Ca2+ levels pro-
mote opening of the permeability transition pores (PTPs) in the mito-
chondrial inner membrane, leading to a decreased ΔΨm, cytochrome
c release, and inhibition of the respiratory chain at complex III, which
is accompanied by an increased ROS production [36,37]. Our results
showing that the DHA-induced increase in mitochondrial ROS is sen-
sitive to RU360, together with a decreased ΔΨm and ATP content,
strongly argue for the role of DHA-induced cytosolic Ca2+ increase
Fig. 6. DHA induces apoptosis in hPASMCs. (A) Flow cytometric determination of cleaved caspase-3-positive cells. (B) Representative immunoﬂuorescence staining for TUNEL-
positive cells (green) and DAPI counterstain. Top shows vehicle (veh)-treated cells and bottom shows cells treated with DHA for 24 h. (C) hPASMCs were preincubated with Tempol
or veh for 2 h and treated overnight with 100 μM DHA. Percentage of apoptotic cells was determined using ﬂow cytometric assay for cleaved caspase-3. (D) Flow cytometric de-
termination presented as decreased orange/green ratio indicative of a reduced MMP, as described under Materials and methods. Data are given as means ± SEM of six independent
experiments. *Pb0.05 vs corresponding veh control group. (E) Cellular ATP content after 6 and 12 h incubation with veh or 100 μMDHA. (F) Cellular ATP/ADP ratio after 6 and 12 h
incubation with veh or 100 μM DHA. Results are means ± SEM of six separate incubations for veh and DHA for each indicated time point. *Pb0.05.
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of ROS in DHA-treated cells, because overall cellular ROS were signiﬁ-
cantly decreased but not completely abolished with RU360.
It has been shown that ROS may cause ER stress and that accumu-
lation of misfolded proteins in the ER lumen can initiate ROS produc-
tion [14,38,39]. Considering a very rapid increase in DHA-induced
ROS, preceding the increase in UPR markers, it is possible that the ini-
tial increase in ROS, generated outside of the ER, affects the ER folding
machinery, leading to UPR and concomitant generation of ER-derived
ROS.
Based on the capacity of Tempol to counteract DHA-induced UPR,
apoptosis, and cell cycle arrest, the DHA-induced oxidative stress
seems to be the initial event triggered by DHA. The failure of RU360
to counteract DHA-mediated attenuation of hPASMC proliferation
(Supplementary Fig. 2) clearly demonstrates a rather weakcontribution of mitochondrial ROS, suggesting that various other cel-
lular ROS sources are responsible for triggering and mediating DHA
effects in hPASMCs. However, the exact intracellular localization and
the relative quantitative aswell as temporal contributions of the various
ROS sources in DHA-treated cells require further investigation.
In this study DHA induced apoptosis in hPASMCs, evidenced by
late apoptotic markers, cleaved caspase-3, and DNA fragmentation.
Considering the capacity of Ca2+ inﬂux into mitochondria and con-
comitantly increased mitochondrial ROS to trigger apoptosis [40], it
is conceivable that a similar mechanism underlies DHA-induced apo-
ptosis in our experimental system. We observed a Ca2+-dependent
increase in mitochondrial ROS and an attenuating effect of Tempol
on caspase-3 cleavage. Furthermore, DHA treatment decreased ΔΨm
in hPASMCs, indicating the opening of the mitochondrial inner mem-
brane PTP, an event associated with the release of proapoptotic
1794 S. Crnkovic et al. / Free Radical Biology & Medicine 52 (2012) 1786–1795molecules from mitochondria [41]. Whether and to what extent C/
EBP homologous protein, a proapoptotic component of UPR [42,43],
contributes to DHA-induced apoptosis remains to be determined.
Conclusion
Based on the results of this comprehensive analysis of molecular
events in DHA-treated primary hPASMCs, we conclude that Ca2+-
dependent induction of oxidative stress is the central and initial event
responsible for induction of UPR, cell cycle arrest, and apoptosis in
DHA-treated hPASMCs. The fact that DHA-mediated induction of oxida-
tive stress, UPR, and apoptosis might be beneﬁcial in SMCs undergoing
remodeling (pulmonary hypertension or stent restenosis), but detri-
mental in SMCs constituting the cap of a stable atherosclerotic plaque
[44], implies that a systemic application of DHA may simultaneously
be both beneﬁcial and harmful. This is of importance, as these pathologic
states may coexist in a patient. Therefore, our ﬁndings should encourage
the development of strategies to achieve targeted, vascular bed-speciﬁc
utilization of both DHA and appropriate antioxidants capable of modu-
lating DHA effects.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.freeradbiomed.2012.02.036
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